help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaquet, D.
Right arrow Articles by Levy-Marchal, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaquet, D.
Right arrow Articles by Levy-Marchal, C.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 6 1949-1953
Copyright © 1999 by The Endocrine Society


Original Studies

High Serum Leptin Concentrations during Catch-Up Growth of Children Born with Intrauterine Growth Retardation1

D. Jaquet, J. Leger, M. D. Tabone, P. Czernichow and C. Levy-Marchal

INSERM U-457, Hôpital R. Debré (D.J., J.L., P.C., C.L.-M.), 75019 Paris; and Centre du Bilan de Santé de l’Enfant (M.D.T.), Paris, France

Address all correspondence and requests for reprints to: Delphine Jaquet, M.D., INSERM U-457, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris, France. E-mail: djacquet{at}infobiogen.fr


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The aim of the study was to investigate how leptin could be involved in catch-up growth of children born with intrauterine growth retardation (IUGR). The study population was made up of 70 newborns with IUGR longitudinally studied during the first 2 yr of life and 35 newborns and 32, 66, and 61 children with normal birth weight aged 3 days, 12 months, and 24 months, respectively. Postnatal patterns of body mass index (BMI) were similar in the 2 groups, but BMI remained significantly lower in IUGR over the study period. In contrast, children born with IUGR aged 1 yr had significantly higher serum leptin levels than normal children (P < 0.0001) independently of BMI. The correlation observed between BMI and serum leptin at birth in both groups and in the control group thereafter disappeared in children born with IUGR. Similarly, sexual dimorphism observed in normal children over the study period was not observed in the IUGR group during the first 2 yr of life. In summary, serum leptin is effective and regulated during the first years of life as it is in older children. Children born with IUGR demonstrate high serum leptin values during the first year of life, with a loss of the regulatory effect of BMI and gender. We suggest that these children develop an adaptative leptin resistance beneficial for their catch-up growth. An alternative hypothesis is that these observations could reflect an adipocyte dysfunction, a consequence of the special time course of adipose tissue development in children born with IUGR.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
LEPTIN, the adipocyte-specific product of the ob gene (1), is known to regulate body weight through a negative feedback signal between the adipose tissue and the hypothalamic centers of satiety (2, 3, 4, 5). In children, as in adults, serum leptin concentrations closely correlate with body weight and body fat mass (6, 7). Girls consistently demonstrate higher serum leptin levels than boys, and this gender difference persists into adulthood (6, 7). Serum leptin concentrations are higher in children than in adults with respect to body fat mass, and it was hypothesized that they developed a relative leptin resistance beneficial for their dynamic energy needs (6). It is now well established that serum leptin is present in cord blood and closely correlates with body weight and fat mass in neonates (8, 9, 10). In a previous study, we demonstrated that leptin is detectable in human fetal cord blood as early as 18 weeks gestation and that development of adipose tissue and accumulation of fat mass are the major determinants of fetal and neonatal serum leptin levels (11). Accordingly, small for gestational age newborns have significantly reduced serum leptin concentrations consistent with the decreased body fat mass (11).

The first 2 yr of life are critical for ponderal growth, with a 3- to 4-fold increase in body weight. A unique pattern of body mass index (BMI) is observed during the same period, with a dramatic increase over the first year followed by a slight decrease during the second year of life (12). Children born with intrauterine growth retardation (IUGR) demonstrate a postnatal catch-up for weight and height growth, especially during the first year of life. This catch-up results in a correction of weight and height deficit in about 90% of children born with IUGR (13).

The aim of our study was to describe the postnatal time course of serum leptin concentrations in children between birth and 2 yr of age, over this critical period of positive energy needs. We have also investigated how leptin is involved in the catch-up growth of children born with IUGR.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Study populations

Neonates and children born with IUGR. Seventy children born with IUGR and previously recruited for a prospective survey of growth and growth factors during the first 2 yr of life were included in the present study (14, 15). IUGR was defined as birth weight below the third percentile for gestational age according to the French growth standard curves reported by Leroy (16). Malformations and/or chromosomal abnormalities or maternal short stature were not considered as exclusion criteria. Other causes for IUGR included pregnancy-induced hypertension, multiple pregnancies, smoking, and heavy alcohol consumption. Children were studied at birth, 3 days of life, and 3, 6, 12 and 24 months of life. Blood samples were taken from the cord at birth and at each visit thereafter.

Control population. The control population was made up of cross-sectional samples of healthy children born with a birth weight above the 25th percentile according to the French growth standard curves reported by Leroy (16). This population included 35 newborns, 32 infants aged 3 days, and 66 and 61 children aged 12 and 24 months, respectively. Blood samples were obtained at birth from the cord and from venous puncture thereafter during a free health examination.

Blood samples were collected after informed parental consent, and the study protocol was approved by the local university ethical committee.

Protocol

Auxologic data. Auxologic data were recorded in all subjects of the two populations. Weight was expressed as crude values in both groups. In the IUGR group, weight was also expressed as SD scores corrected for gestational age and sex according to the extrauterine growth standard curves reported by Largo et al. (17) from birth to 3 months of age. From 6–24 months of age, growth standard curves, as reported by Sempe, were used (18). Weight for height was expressed as the BMI (kilograms per m2).

Serum leptin measurement. All sera were stored at -80 C until assayed. Serum leptin concentrations were measured using a specific RIA (Linco Research, Inc., St. Charles, MO) as previously described by Maffei et al. (19). The sensitivity of the assay was 0.5 ng/mL, with intra- and interassay coefficients of variation of 5.2% and 8.7%, respectively, at 2.3 ng/mL.

Statistical analysis

All data were entered and analyzed on the SAS statistical package. (SAS Institute, Inc., Cary, NC). Results are expressed as means (SD). Serum leptin values were log transformed for the statistical analysis.

The statistical significance of differences between IUGR and control groups and between gender in each group were tested by unpaired t test. For the longitudinal analysis in the IUGR group, comparisons of mean values were made using a paired t test. Correlations between variables were assessed using linear regression analysis.

Multivariate models (general linear model procedure) were fitted with log-transformed leptin values as the dependent variable and group (IUGR vs. control), gender, and BMI as explanatory variables at each time point. A P value of 0.05 was regarded as significant.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Clinical characteristics

Clinical characteristics of the two populations are summarized in Table 1Go. There was no significant difference in gestational age between the two groups of newborns (39.48 ± 1.65 vs. 38.92 ± 1.95 weeks). As expected, body weight was higher in the control group than in the IUGR group (3.42 ± 0.56 vs. 2.03 ± 0.30 kg; P < 0.0001) at birth. The IUGR group showed a dramatic catch-up growth for weight during the first year of life (mean weight, -2.58 ± 0.52 SD score at birth vs. -0.94 ± 0.64 SD score at 12 months; P < 0.0001). Weight growth velocity decreased thereafter. As a result, mean weights at 12 and 24 months did not significantly differ (-0.94 ± 0.64 vs. -1.12 ± 0.92 SD score; Table 1Go). However, body weight remained significantly lower in children born with IUGR than in normal children at 12 and 24 months (P < 0.0001 at the two time points).


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical characteristics of IUGR and control children from birth to 24 months of age

 
Figure 1Go shows the postnatal pattern of BMI in both groups. BMI was higher in normal newborns than in IUGR (13.9 ± 1.3 vs. 9.9 ± 0.9 kg/m2; P < 0.0001) at birth. In IUGR, BMI significantly decreased during the first 3 days (P = 0.006). No such variation was observed in normal newborns. As expected in normal children, BMI was maximal at 12 months of life and significantly decreased during the second year of life (P < 0.0001). Children born with IUGR demonstrated a similar postnatal pattern of BMI. However, BMI remained significantly lower in the IUGR group at 12 and 24 months compared with that in the control group (P = 0.0001 and P = 0.008, respectively; Fig. 1Go). In our study, at 1 yr of age, body weight, height, and BMI did not significantly differ between children born with symmetric or asymmetric IUGR (ponderal index below the third percentile).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1. Postnatal pattern of BMI in IUGR group at birth, 3 days of age, and 3, 6, 12, and 24 months of age and in the control group at birth, 3 days of age, and 12 and 24 months of age. P values are given for mean comparisons of BMI between IUGR and controls at each time point (*, P < 0.0001; {ddagger}, P = 0.0008).

 
Serum leptin concentrations at birth and up to the second year of life

Figure 2Go shows the postnatal pattern of serum leptin concentrations in both groups. The highest serum leptin levels were observed at birth in the control and IUGR groups (7.96 ± 8.3 and 4.48 ± 6.7 ng/mL). IUGR newborns had significantly lower levels (P < 0.0001). During the first 3 days of life, serum leptin values dramatically decreased in the two groups and remained significantly lower in the IUGR group (1.86 ± 0.84 vs. 1.30 ± 0.48 ng/mL; P < 0.0001; Fig. 2Go).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Postnatal pattern of serum leptin concentrations in IUGR group at birth, 3 days of age, and 3, 6, 12, and 24 months of age and in the control group at birth, 3 days of age, and 12 and 24 months of age. P values are given for mean comparisons of log-transformed serum leptin concentrations between IUGR and controls at each time point (*, P < 0.0001; ¶, P = 0.75).

 
In a model of covariate analysis with age and BMI as covariates, the decrease in leptin levels observed between 0 and 3 days remained significant regardless of changes in BMI.

This model also indicates that differences between IUGR and control groups were not statistically significant after correction for BMI at birth and 3 days.

Serum leptin concentrations increased during the first year of life in normal children (P < 0.0001) as well as in children born with IUGR (P < 0.0001) and decreased significantly thereafter in the two groups (P < 0.02 and P < 0.0001, respectively). Serum leptin concentrations at 12 months were significantly higher in the IUGR group than in the control group (P < 0.0001), and this difference remained significant after adjustment for gender and BMI (P = 0.03).

At 1 yr of age, body weight, height, and BMI did not significantly differ between children born with symmetric or asymmetric IUGR (ponderal index below the third percentile). We did not observe any influence of body proportionality at birth (estimated by ponderal index) on serum leptin levels at 1 yr of age in children born with IUGR after adjustment for gender and BMI.

At 2 yr of age, no significant difference in leptin concentrations was observed between the two groups (P = 0.75; Fig. 2Go).

Usual determinants of serum leptin concentrations

At birth, serum leptin values were significantly correlated with body weight (r = 0.54, P = 0.0008 and r = 0.30, P = 0.01, respectively) and with BMI (r = 0.57, P = 0.0005 and r = 0.22, P = 0.05, respectively) in both control and IUGR groups. No significant correlation was observed between serum leptin values and body weight after birth and until 24 months of age in both groups. As expected, leptin was significantly correlated with BMI in normal children at 12 (r = 0.44, P = 0.0002) and 24 months of age (r = 0.30, P = 0.02). In contrast, no such association was observed in children born with IUGR after 3 days of life and during the first 2 yr thereafter (r = 0.06, P = 0.66 at 12 months and r = 0.14, P = 0.44 at 24 months).

In children born with IUGR, serum leptin levels peaked at 6 months, whereas BMI increased significantly between 6 and 12 months (P = 0.008; Figs. 1Go and 2Go). However, the longitudinal study did not show any significant correlation between baseline serum leptin concentrations and changes in BMI over the subsequent time interval at each time point of follow-up. Therefore, in this population, serum leptin levels were not predictive for variation in BMI. Conversely, variations in BMI did not predict serum leptin levels. Likewise, in IUGR, no correlation was found between serum leptin concentrations and weight gain, expressed as SD score, during this period.

At birth, serum leptin concentrations in the two groups were higher in girls than in boys, and this gender difference was significant [10.81 ± 9.3 vs. 6.28 ± 6.5 ng/mL (P = 0.04) in the control group and 4.88 ± 8.6 vs. 3.97 ± 2.95 ng/mL (P = 0.03) in the IUGR group]. This gender difference persisted throughout the first 2 yr of life in normal children, but disappeared in children born with IUGR as early as 3 days of age. Therefore, in contrast with normal children, we did not observe any effect of determinants usually known to regulate serum leptin concentrations in children born with IUGR during postnatal catch-up growth.


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
As expected, serum leptin is detectable in serum from normal children less than 2 yr of age. Values are positively correlated with BMI, as previously reported in newborns (8, 9, 10, 11) and prepubertal children (6, 7). In addition, we observed that sexual dimorphism, with higher serum leptin values in girls, already exists during this period. However, we did not observe the association between serum leptin concentrations and body weight described in newborns (8, 9, 10, 11) and older children (6, 7). This lack of relationship could be explained by the fact that body weight does not reflect body fat mass during this period.

Serum leptin concentrations are higher in prepubertal children than in adults with respect to body fat mass. Consequently, Hassink et al. hypothesized that children would develop a relative leptin resistance beneficial for their positive energy needs (6). The first year of life is characterized by maximal weight growth velocity. Mean BMI values in prepubertal children reported by Rolland-Cachera et al. are lower than those in 12-month-old children (16.2 ± 1.4 vs. 17.4 ± 1.4) (12). However, in our study, serum leptin values observed at 12 months in normal children are lower than those reported in prepubertal children (2.89 ± 1.16 vs. 4–8 ng/mL) (6, 7). Consequently, we cannot suggest that normal children develop leptin resistance early in life. Higher leptin values observed in older children could be explained, rather, by the onset of puberty, as suggested by previous studies (20, 21).

Newborns consistently demonstrate high serum leptin values that dramatically decrease during the first days of life. Unlike Manchini et al., who explained this decrease by variations in BMI (22), we demonstrate that the variation in serum leptin concentrations during this period is independent of intrauterine growth status and variations in BMI. However, serum leptin correlated with BMI at birth and 3 days of age in both groups. It is tempting to speculate that the high serum leptin concentrations observed at birth are an adaptative pathway to prepare for the drastic changes in feeding status and energy balance that occur after birth. The decrease in serum leptin between birth and 3 days of life would reflect the return to expected values with respect to body fat mass. Taken together, these results suggest that the loop by which leptin regulates energy homeostasis is already effective at birth and is able to contribute to the metabolic adaptations for extrauterine life. This regulatory loop would remain effective even if adipose tissue development is defective, as in IUGR.

Children born with IUGR have significantly higher serum leptin values than normal children at the end of the first year of life regardless of BMI and gender, and this difference tends to disappear during the second year of life. Moreover, the relationships observed at birth between serum leptin values and its usual determinants, such as BMI and gender, disappear in these children during this period. It has been reported that low leptin values relative to body weight would be predictive of weight gain (23, 24). We did not observe such a correlation in children born with IUGR during the first 2 yr of life, although it was a critical period for children born with IUGR, who demonstrate a dramatic catch-up growth for weight and height. Therefore, we could speculate that these children develop leptin resistance to increase their energy balance. Thus, leptin resistance could mask the association between serum leptin and its usual determinants, making them less efficient to regulate serum leptin concentrations.

Leptin resistance in this population could be an adaptative pathway beneficial for catch-up growth. However, an alternative hypothesis is that high serum leptin concentrations would reflect a defect in adipose tissue functions. The special time course of adipose tissue development in IUGR is characterized by a dramatically reduced body fat mass at birth (25) followed by a drastic increase in weight growth velocity during the first year of life. We cannot exclude that this postponed growth of adipose tissue could affect the sensitivity of regulatory systems of leptin synthesis and secretion in adipose tissue. The increased risk of obesity in adults born with IUGR described by Ravelli et al. (26) also supports this hypothesis. It would be of considerable interest to investigate serum leptin concentrations with respect to body fat mass in adults born with IUGR to further document this hypothesis.

In summary, serum leptin is present and appears to be effective and regulated during the first years of life in healthy children under the same conditions as it is in older children. Leptin could be one of the hormonal components involved in metabolic and energetic adaptations at birth. Children born with IUGR consistently demonstrate high serum leptin values with respect to BMI during the first year of life. We suggest two hypotheses to explain this observation: 1) these children could develop an adaptative leptin resistance beneficial for their catch-up growth; and 2) high serum leptin concentrations could reflect an adipocyte defect, consequence of the special time course of adipose tissue development in fetuses and children born with IUGR. Both hypotheses should be tested in animal models and in humans.


    Acknowledgments
 
The authors acknowledge the contribution of the nursing staff of the obstetric department of the Hôpital R. Debré and the nursing and medical staff of the Centre du Bilan de Santé de l’Enfant (Paris, France).


    Footnotes
 
1 This work was supported by a fellowship (to D.J.) from Novo-Nordisk (France). Back

Received November 16, 1998.

Revised February 17, 1999.

Accepted February 4, 1999.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432.[CrossRef][Medline]
  2. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med. 334:292–295.[Abstract/Free Full Text]
  3. Pelleymonter MA, Cullen MJ, Baker MB, et al. 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540–543.[Abstract/Free Full Text]
  4. Halaas JL, Gajiwala KS, Maffei M, et al. 1995 Weight reducing effects of the plasma protein encoded by obese gene. Science. 269:543–546.[Abstract/Free Full Text]
  5. Schwartz MW, Baskin DG, Bukowski TR, et al. 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:531–535.[Abstract]
  6. Hassink SG, Sheslow DV, De Lancey E, Opentanova I, Considine RV, Caro JF. 1996 Serum leptin concentrations in children with obesity: relationship to gender and development. Pediatrics. 98:201–203.[Abstract/Free Full Text]
  7. Caprio S, Tamborlane WV, Silver D, et al. 1996 Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol. 271:E626–E630.
  8. Sivan E, Lin WM, Homko CJ, Reece EA, Boden G. 1997 Leptin is present in human cord blood. Diabetes. 46:917–919.[Abstract]
  9. Matsuda J, Yokota I, Lida M, et al. 1997 Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab. 82:1642–1644.[Abstract/Free Full Text]
  10. Schrubing C, Kiess W, Englaro P, et al. 1997 Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab. 82:1480–1483.[Abstract/Free Full Text]
  11. Jaquet D, Léger J, Lévy-Marchal C, Oury JF, Czernichow P. 1998 ontogeny of leptin in human fetuses and newborn: Impact of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab. 83:1243–1246.[Abstract/Free Full Text]
  12. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. 1991 Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr. 45:13–21.[Medline]
  13. Albertsson-Wikland K, Wennergren G, Wenergren M, Vibergsson G, Rosberg S. 1993 longitudinal follow-up of growth in children born small for gestational age. Acta Paediatr. 82:438–443.[Medline]
  14. Léger J, Limoni C, Czernichow P. 1997 prediction of outcome of growth at 2 years of age in neonates with intrauterine growth retardation. Early Hum Dev. 48:211–223.[CrossRef][Medline]
  15. Léger J, Noel M, Limal JM, Czernichow P. 1996 Growth factors and intrauterine growth retardation. serum growth hormone, insulin-like growth factor I and IGF-binding protein 3 levels in children with intrauterine growth retardation compared to normal control subjects: prospective study from birth to two years of age. Pediatr Res. 40:101–107.[Medline]
  16. Leroy B, Lefort F. 1971 A propos du poids et de la taille des nouveaux-nés à la naissance. Rev Fr Gynecol. 66:391–396.
  17. Largo RH, Waïli R, Duc O, Fanconi A, Prader A. 1980 Evaluation of perinatal growth. Helv Paediatr Acta. 35:419–436.[Medline]
  18. Sempe M, Pedron O, Roy-Pernot MP. 1979 Auxologie méthodes et séquences. Paris, Théraplix.
  19. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 11:1155–1161.
  20. Garcia-Mayor RV, Amalia Andrade M, Rios M, et al. 1997 Serum leptin levels in normal children: relationship to age, gender, body-mass index, pituitary gonadal hormones and pubertal stage. J Clin Endocrinol Metab. 82:2849–2855.[Abstract/Free Full Text]
  21. Mantzoros CS, Flier JS, Rogol AD. 1997 A longitudinal assessment of hor- monal and physical alteration during normal puberty in boys. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab. 82:1066–1070.[Abstract/Free Full Text]
  22. Marchini G, Fried G, Ostlund E, Hagenas L. 1998 Plasma leptin in infants: relation to birth weight and weight loss. Pediatrics. 101:429–432.[Abstract/Free Full Text]
  23. Ravussin E, Pratley RE, Maffei M, et al. 1997 Relatively low plasma leptin concentrations preced weight gain in Pima Indians. Nat Med. 3:1–3.[CrossRef][Medline]
  24. Friedman JM, Halaas JL. 1998 Leptin and the regulation of body weight in mammals. Nature. 395:763–770.[CrossRef][Medline]
  25. Lapillonne A, Braillon P, Chatelain PG, et al. 1997 Body composition in appropriate and small for gestational age infants. Acta Paediatr. 86:196–200.[Medline]
  26. Ravelli GP, Stein ZA, Susser MW. 1976 Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 295:349–353.[Abstract]



This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S. Kayemba-Kay's, M. P P Geary, J. Pringle, C. H Rodeck, J. C P Kingdom, and P. C Hindmarsh
Gender, smoking during pregnancy and gestational age influence cord leptin concentrations in newborn infants
Eur. J. Endocrinol., September 1, 2008; 159(3): 217 - 224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. A. Duffield, T. Vuocolo, R. Tellam, B. S. Yuen, B. S. Muhlhausler, and I. C. McMillen
Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1413 - R1419.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C.P. Franco, E. M.S. Higa, V. D'Almeida, F. G. de Sousa, A. L. Sawaya, Z. B. Fortes, and R. Sesso
Homocysteine and Nitric Oxide Are Related to Blood Pressure and Vascular Function in Small-for-Gestational-Age Children
Hypertension, August 1, 2007; 50(2): 396 - 402.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. Siahanidou, H. Mandyla, G.-P. Papassotiriou, I. Papassotiriou, and G. Chrousos
Circulating levels of adiponectin in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F286 - F290.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter
Small for Gestational Age: Short Stature and Beyond
Endocr. Rev., April 1, 2007; 28(2): 219 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Mohn, V. Chiavaroli, M. Cerruto, A. Blasetti, C. Giannini, T. Bucciarelli, and F. Chiarelli
Increased Oxidative Stress in Prepubertal Children Born Small for Gestational Age
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1372 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G. K Bhat, T. M Plant, and D. R Mann
Relationship between serum concentrations of leptin, soluble leptin receptor, testosterone and IGF-I, and growth during the first year of postnatal life in the male rhesus monkey, Macaca mulatta
Eur. J. Endocrinol., July 1, 2005; 153(1): 153 - 158.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. C. McMillen, C. L. Adam, and B. S. Muhlhausler
Early origins of obesity: programming the appetite regulatory system
J. Physiol., May 15, 2005; 565(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
I. C. Mcmillen and J. S. Robinson
Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity, and Programming
Physiol Rev, April 1, 2005; 85(2): 571 - 633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. J. Edwards, J. R. McFarlane, K. G. Kauter, and I. C. McMillen
Impact of periconceptional nutrition on maternal and fetal leptin and fetal adiposity in singleton and twin pregnancies
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R39 - R45.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. Huxley, C. G. Owen, P. H. Whincup, D. G. Cook, S. Colman, and R. Collins
Birth Weight and Subsequent Cholesterol Levels: Exploration of the "Fetal Origins" Hypothesis
JAMA, December 8, 2004; 292(22): 2755 - 2764.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Soto, R. A. Bazaes, V. Pena, T. Salazar, A. Avila, G. Iniguez, K. K. Ong, D. B. Dunger, and M. V. Mericq
Insulin Sensitivity and Secretion Are Related to Catch-Up Growth in Small-for-Gestational-Age Infants at Age 1 Year: Results from a Prospective Cohort
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3645 - 3650.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. Arfai, P. D. Pitukcheewanont, M. I. Goran, C. J. Tavare, L. Heller, and V. Gilsanz
Bone, Muscle, and Fat: Sex-related Differences in Prepubertal Children
Radiology, August 1, 2002; 224(2): 338 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Palacio, M. Lopez, F. Perez-Bravo, F. Monkeberg, and L. Schlesinger
Leptin Levels Are Associated with Immune Response in Malnourished Infants
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3040 - 3046.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Ong, J. Kratzsch, W. Kiess, and D. Dunger
Circulating IGF-I Levels in Childhood Are Related to Both Current Body Composition and Early Postnatal Growth Rate
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1041 - 1044.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaquet, D.
Right arrow Articles by Levy-Marchal, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaquet, D.
Right arrow Articles by Levy-Marchal, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals